A double-blind randomized study assessing safety and efficacy following one-year adjunctive treatment with bitopertin, a glycine reuptake inhibitor, in Japanese patients with schizophrenia
Crossref DOI link: https://doi.org/10.1186/s12888-016-0778-9
Published Online: 2016-03-15
Published Print: 2016-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Hirayasu, Yoshio
Sato, Shin-Ichi
Takahashi, Hideaki
Iida, Sayaka
Shuto, Norifumi
Yoshida, Seitaro
Funatogawa, Takashi
Yamada, Takahito
Higuchi, Teruhiko